France· FR:65942815
VITRAKVI 20 mg/mL, solution buvable
A medicinal product containing sulfate de larotrectinib, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE LAROTRECTINIB
- Manufacturer
- BAYER AG (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009301880191 flacon en verre avec fermeture de sécurité enfant de 100 mlEUR 5.73
- cip1334009302303432 flacon(s) en verre avec fermeture de sécurité enfant de 50 mlEUR 2.69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate de larotrectinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVITRAKVI 20 MG/ML SOLUCION ORAL, 1 frasco de 100 mlBayer Ag
- SwedenVITRAKVI 20 mg/ml (1000 mg/50 ml) Oral lösningBayer AG
- BelgiumVitrakvi 20 mg/mlBayer
- IrelandVITRAKVI 20 mg/ml Oral solutionBayer AG
- IcelandVITRAKVIBayer AG
- NetherlandsVitrakvi 20 mg/ml, drankBayer AG
- NorwayVitrakviBayer AG
- PolandVitrakviBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vitrakvi
- Liechtenstein · Vitrakvi
- Norway · Vitrakvi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb23d62c-5690-4c45-926a-ef1a2982de6c GET /v1/drugs/eb23d62c-5690-4c45-926a-ef1a2982de6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65942815",
"date_amm": "2019-09-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1385",
"substance": "SULFATE DE LAROTRECTINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about sulfate de larotrectinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.